cobalt has been researched along with ursodeoxycholic acid in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ab Rahim, S; Abdu, N; Hanafi, NI; Hasani, H; Md Noor, J; Mohamed, AS; Osman, NJ; Sheikh Abdul Kadir, SH; Siran, R | 1 |
Ab Rahim, S; Abdul Hamid Hasani, N; Hanafi, NI; Md Noor, J; Mohamed, AS; Sheikh Abdul Kadir, SH; Siran, R | 1 |
2 other study(ies) available for cobalt and ursodeoxycholic acid
Article | Year |
---|---|
Ursodeoxycholic acid upregulates ERK and Akt in the protection of cardiomyocytes against CoCl2.
Topics: Animals; Cardiotonic Agents; Cell Hypoxia; Cell Survival; Cells, Cultured; Cobalt; Extracellular Signal-Regulated MAP Kinases; Myocytes, Cardiac; Proto-Oncogene Proteins c-akt; Rats; Rats, Sprague-Dawley; Signal Transduction; Sphingomyelin Phosphodiesterase; Up-Regulation; Ursodeoxycholic Acid | 2016 |
Ursodeoxycholic acid protects cardiomyocytes against cobalt chloride induced hypoxia by regulating transcriptional mediator of cells stress hypoxia inducible factor 1α and p53 protein.
Topics: Animals; Cell Hypoxia; Cell Proliferation; Cell Survival; Cells, Cultured; Cobalt; Fingolimod Hydrochloride; Gene Expression Regulation; Hypoxia-Inducible Factor 1, alpha Subunit; Myocytes, Cardiac; Pertussis Toxin; Protective Agents; Rats; Rats, Sprague-Dawley; Receptors, Lysosphingolipid; Signal Transduction; Tumor Suppressor Protein p53; Ursodeoxycholic Acid | 2017 |